Dokkyo Medical University · Saitama Medical Center: Department of Diabetes, Endocrinology and Hematology · 准教授

Research keywordstype 2 diabetes・glycemic markers・oral semaglutide・telemedicine for diabetes・skin autofluorescence・diabetic complications・seasonal glycemic variation

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Long term effect of oral semaglutide on glycemic control. An extensional observational study with the periods of 2 years from baseline., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Med J, 2024年2024 · 論文
• Association of the ratio of glycoalbumin to hemoglobin A1c with season change and the COVID-19 pandemic in patients with type 2 diabetes mellitus., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Cureus, 2024年2024 · 論文
• Analysis of five cases showing false-high Hemoglobin A1c due to reduced catalase activity., Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, Yamauchi M, Tsuchiya T, Takebayashi K, Shimozawa N, Koga M, Hashimoto K, Endocr J, 2023年2023 · 論文
• Changing from a Dipeptidyl Peptidase (DPP)-4 Inhibitor to Oral Semaglutide in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Observational Study., Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K., Dokkyo Medical J., 2（Jun）, 123-129, 2023年2023 · 論文

• Official profile